|
1
|
Huse JT and Holland EC: Targeting brain
cancer: Advances in the molecular pathology of malignant glioma and
medulloblastoma. Nat Rev Cancer. 10:319–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davis FG, McCarthy BJ, Freels S, Kupelian
V and Bondy ML: The conditional probability of survival of patients
with primary malignant brain tumors: Surveillance, epidemiology,
and end results (SEER) data. Cancer. 85:485–491. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meyer MA: Malignant gliomas in adults. N
Engl J Med. 359:18502008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kanu OO, Mehta A, Di C, Lin N, Bortoff K,
Bigner DD, Yan H and Adamson DC: Glioblastoma multiforme: A review
of therapeutic targets. Expert Opin Ther Targets. 13:701–718. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giese A, Bjerkvig R, Berens ME and
Westphal M: Cost of migration: Invasion of malignant gliomas and
implications for treatment. J Clin Oncol. 21:1624–1636. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hussain SF, Yang D, Suki D, Aldape K,
Grimm E and Heimberger AB: The role of human glioma-infiltrating
microglia/macrophages in mediating antitumor immune responses.
Neuro Oncol. 8:261–279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Graeber MB, Scheithauer BW and Kreutzberg
GW: Microglia in brain tumors. Glia. 40:252–259. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kushchayev SV, Kushchayeva YS, Wiener PC,
Scheck AC, Badie B and Preul MC: Monocyte-derived cells of the
brain and malignant gliomas: The double face of Janus. World
Neurosurg. 82:1171–1186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang I, Han SJ, Kaur G, Crane C and Parsa
AT: The role of microglia in central nervous system immunity and
glioma immunology. J Clin Neurosci. 17:6–10. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Charles NA, Holland EC, Gilbertson R,
Glass R and Kettenmann H: The brain tumor microenvironment. Glia.
60:502–514. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
da Fonseca AC and Badie B: Microglia and
macrophages in malignant gliomas: Recent discoveries and
implications for promising therapies. Clin Dev Immunol.
2013:2641242013.PubMed/NCBI
|
|
12
|
Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen
L, Xiao HL, Wang B, Yi L, Wang QL, et al: Tumor-associated
microglia/macrophages enhance the invasion of glioma stem-like
cells via TGF-β1 signaling pathway. J Immunol. 189:444–453. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Markovic DS, Vinnakota K, Chirasani S,
Synowitz M, Raguet H, Stock K, Sliwa M, Lehmann S, Kälin R, van
Rooijen N, et al: Gliomas induce and exploit microglial MT1-MMP
expression for tumor expansion. Proc Natl Acad Sci USA.
106:12530–12535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin HC, Song TY and Hu ML:
S-Adenosylhomocysteine promotes the invasion of C6 glioma cells via
increased secretion of matrix metalloproteinase-2 in murine
microglial BV2 cells. Toxicol Sci. 112:322–330. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Evans SM, Judy KD, Dunphy I, Jenkins WT,
Hwang WT, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM,
et al: Hypoxia is important in the biology and aggression of human
glial brain tumors. Clin Cancer Res. 10:8177–8184. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
16. Kessler J, Hahnel A, Wichmann H, Rot
S, Kappler M, Bache M and Vordermark D: HIF-1α inhibition by siRNA
or chetomin in human malignant glioma cells: Effects on hypoxic
radioresistance and monitoring via CA9 expression. BMC Cancer.
10:6052010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang L, Lin C, Wang L, Guo H and Wang X:
Hypoxia and hypoxia-inducible factors in glioblastoma multiforme
progression and therapeutic implications. Exp Cell Res.
318:2417–2426. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen Z, Kauttu T, Seppänen H, Vainionpää
S, Ye Y, Wang S, Mustonen H and Puolakkainen P: Both macrophages
and hypoxia play critical role in regulating invasion of gastric
cancer in vitro. Acta Oncol. 52:852–860. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen Z, Seppänen H, Vainionpää S, Ye Y,
Wang S, Mustonen H and Puolakkainen P: IL10, IL11, IL18 are
differently expressed in CD14+ TAMs and play different
role in regulating the invasion of gastric cancer cells under
hypoxia. Cytokine. 59:352–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mu L, Wang J, Chen Y, Li L, Guo X, Zheng S
and Jing C: Hypoxia-inducible factor-1α and semaphorin4D genes
involved with tumor-associated macrophage-induced metastatic
behavior and clinical significance in colon cancer. Chin Med J.
127:3568–3575. 2014.PubMed/NCBI
|
|
21
|
Zhao P, Gao D, Wang Q, Song B, Shao Q, Sun
J, Ji C, Li X, Li P and Qu X: Response gene to complement 32
(RGC-32) expression on M2-polarized and tumor-associated
macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4.
Cell Mol Immunol. 12:692–699. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen S, Han M, Chen W, He Y, Huang B, Zhao
P, Huang Q, Gao L, Qu X and Li X: KIF1B promotes glioma migration
and invasion via cell surface localization of MT1-MMP. Oncol Rep.
35:971–977. 2016.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao L, Wang Y, Xue Y, Lv W, Zhang Y and
He S: Critical roles of chemokine receptor CCR5 in regulating
glioblastoma proliferation and invasion. Acta Biochim Biophys Sin.
47:890–898. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pham K, Luo D, Liu C and Harrison JK:
CCL5, CCR1 and CCR5 in murine glioblastoma: Immune cell
infiltration and survival rates are not dependent on individual
expression of either CCR1 or CCR5. J Neuroimmunol. 246:10–17. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin S, Wan S, Sun L, Hu J, Fang D, Zhao R,
Yuan S and Zhang L: Chemokine C-C motif receptor 5 and C-C motif
ligand 5 promote cancer cell migration under hypoxia. Cancer Sci.
103:904–912. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Sarkar S, Cua R, Zhou Y, Hader W
and Yong VW: A dialog between glioma and microglia that promotes
tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.
Carcinogenesis. 33:312–319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zagzag D, Lukyanov Y, Lan L, Ali MA,
Esencay M, Mendez O, Yee H, Voura EB and Newcomb EW:
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in
glioblastoma: Implications for angiogenesis and glioma cell
invasion. Lab Invest. 86:1221–1232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Günthner R and Anders HJ:
Interferon-regulatory factors determine macrophage phenotype
polarization. Mediators Inflamm. 2013:7310232013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Génin P, Algarté M, Roof P, Lin R and
Hiscott J: Regulation of RANTES chemokine gene expression requires
cooperativity between NF-kappa B and IFN-regulatory factor
transcription factors. J Immunol. 164:5352–5361. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Guan X and Ma X: Interferon
regulatory factor 1 is an essential and direct transcriptional
activator for interferon γ-induced RANTES/CCl5 expression in
macrophages. J Biol Chem. 280:24347–24355. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yarilina A, Park-Min KH, Antoniv T, Hu X
and Ivashkiv LB: TNF activates an IRF1-dependent autocrine loop
leading to sustained expression of chemokines and STAT1-dependent
type I interferon-response genes. Nat Immunol. 9:378–387. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Holtschke T, Löhler J, Kanno Y, Fehr T,
Giese N, Rosenbauer F, Lou J, Knobeloch KP, Gabriele L, Waring JF,
et al: Immunodeficiency and chronic myelogenous leukemia-like
syndrome in mice with a targeted mutation of the ICSBP gene. Cell.
87:307–317. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koh MY, Nguyen V, Lemos R Jr, Darnay BG,
Kiriakova G, Abdelmelek M, Ho TH, Karam J, Monzon FA, Jonasch E, et
al: Hypoxia-induced SUMOylation of E3 ligase HAF determines
specific activation of HIF2 in clear-cell renal cell carcinoma.
Cancer Res. 75:316–329. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun L, Li H, Chen J, Iwasaki Y, Kubota T,
Matsuoka M, Shen A, Chen Q and Xu Y: PIASy mediates hypoxia-induced
SIRT1 transcriptional repression and epithelial-to-mesenchymal
transition in ovarian cancer cells. J Cell Sci. 126:3939–3947.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu YC, Ling TY, Lu SH, Kuo HC, Ho HN, Yeh
SD, Shen CN and Huang YH: Chemotherapeutic sensitivity of
testicular germ cell tumors under hypoxic conditions is negatively
regulated by SENP1-controlled sumoylation of OCT4. Cancer Res.
72:4963–4973. 2012. View Article : Google Scholar : PubMed/NCBI
|
